GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ABCG2, ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
13.0858 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
12.7934 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FLT3, RORC, SLC6A3, SRC, TEK, TYR |
11.5873 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APEX1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SLC6A3, SRC, TEK, TYR |
11.0737 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, XDH |
9.43744 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.4075 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.40642 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
9.01596 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
8.86643 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
8.79424 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
8.79424 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
8.69587 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, SRC, TEK |
8.64886 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
8.6207 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
8.48609 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
8.43126 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SLC6A3, SRC |
8.07544 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
8.07544 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
7.93518 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESRRB, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
7.93518 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EPHX1, EPHX2, KDR, SLC6A3, SRC |
7.89766 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX1, EPHX2, FABP3, FUT7, GLO1, HSPA1A, MIF, PIM1, PPARA, TYR, XDH |
7.7433 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, DRD2, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, PTPN1, SRC, TEK, XDH |
7.71058 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, TEK |
7.58807 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
7.44101 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
7.38359 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
7.31649 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
7.11017 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
7.03591 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
7.03057 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AKR1C3, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
7.03057 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, EPHX2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PPARA |
7.01638 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.92323 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
6.91386 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
6.8669 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
6.81122 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PPARA, RORC, SRC, TOP2A |
6.66313 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX2, HSPA1A, SLC6A3 |
6.53771 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
6.47654 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
6.4424 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
6.40198 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, KDR, SLC6A2, SLC6A3, SRC |
6.40198 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.37428 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.31766 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, RORC, SMAD3, SRC |
6.2349 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.21511 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
6.18096 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, ADRA2C, AKR1C3, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
6.17502 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.05279 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC, TOP2A |
5.97271 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, ADRA2C, APEX1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, IGF1R, INSR, KCNA3, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
5.97176 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.91815 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH |
5.90716 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH |
5.88982 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
5.81349 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, ADRA2C, AKR1C3, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.79755 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, EGFR, INSR, MET, SRC, TEK, XDH |
5.79755 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.75328 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.75328 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
5.75328 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.73412 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
5.68057 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, BCL2, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
5.60465 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.60465 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, RORC, SMAD3, SRC |
5.60465 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
5.59253 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.54233 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.54233 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.49857 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.43888 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
5.4361 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.4184 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.3805 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AKR1C3, ALPL, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
5.32027 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
5.29068 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.27898 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.25656 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.24069 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.18492 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, INSR, SLC6A2, SLC6A3, SMAD3 |
5.17925 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.155 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.12078 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
5.12078 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HSD17B1, HSD17B2 |
5.12078 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
5.11635 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
5.11635 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
5.11307 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, ADRA2C, DRD2, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
5.0813 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, PTPN1, SRC, XDH |
5.06175 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, MET, MIF, PPARA |
4.97175 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.94043 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
4.9375 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.91987 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
4.90218 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FLT3, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.83446 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX1, EPHX2, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
4.82802 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, HSPA1A, KDR, MET, MIF, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK |
4.82242 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, AKR1C3, CYP1A1, DRD3, EPHX2, FABP3, FLT3, PPARA, RORC, SRC, TEK |
4.82242 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, ADRA2C, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, INSR, KCNA3, MIF, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
4.73914 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, MIF, SRC |
4.73757 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
4.72529 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK |
4.69822 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, GPR35, SMAD3 |
4.67836 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
4.6178 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.59153 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, CYP19A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.51143 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.50746 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SMAD3, SRC, XDH |
4.50584 |
[BP] GO:0065009 |
regulation of molecular function
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.44682 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, SLC6A3 |
4.4036 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.4036 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.39884 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.39884 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADRA2A, ADRA2C, AKR1C3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
4.3551 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
4.3551 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.29873 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK |
4.25585 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.25585 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
4.17715 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNA3, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.15373 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.14817 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.14305 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADRA2A, ADRA2C, AKR1C3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
4.14305 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.14305 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.14305 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
4.11638 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, AKR1C3, APEX1, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
4.08791 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.08498 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, RORC, SRC |
4.08498 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.08498 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.08498 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
4.06382 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK |
4.05739 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
4.05336 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK |
4.05202 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, ESR2, FLT3, HSPA1A, INSR, MET, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.03327 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
4.02676 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.99168 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TOP2A |
3.98254 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD2, DRD3, EGFR, ESR1, FABP4, KDR, MET, MIF, MMP12, PPARA, SLC6A3, SMAD3, TEK |
3.97356 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.97327 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.96739 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
3.9485 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
3.94431 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.94011 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.93327 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.93173 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.90685 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.87413 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK |
3.87383 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APEX1, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
3.85755 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADRA2A, AURKB, BCL2, CA2, CA7, DRD2, DRD3, EGFR, KDR, MIF, SRC |
3.8455 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.8283 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.82508 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTPN1, SRC |
3.80994 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, MIF, PPARA |
3.80994 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK, XDH |
3.80056 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, MMP2, MMP9, SRC, TOP2A |
3.7985 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADRA2A, ADRA2C, AKR1C3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
3.7985 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, INSR, MET, SRC, TEK |
3.79558 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.7568 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.74922 |
[BP] GO:0042752 |
None
|
DRD2, DRD3, DRD4, PPARA, RORC, TOP2A |
3.74922 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
3.74766 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.73228 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
3.7212 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.71027 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.71027 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, INSR, MIF, MMP12, SMAD3, SRC |
3.71027 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.70504 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
3.66678 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
3.5763 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5763 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.5763 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5763 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.5763 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5763 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, AKR1C3, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, EPHX2, HSPA1A, MIF, MMP2, MMP9, NUAK1, PPARA, PTPN1, SLC6A2, SMAD3, SRC, TEK, TOP2A |
3.5763 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.57374 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, EGFR |
3.57195 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, MIF, PTPN1, SMAD3, SRC, TEK, XDH |
3.57057 |
[BP] GO:0055080 |
cation homeostasis
|
ABCG2, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
3.55432 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.55432 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
3.5493 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
3.54076 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
3.53797 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
3.51657 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SRC |
3.51352 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.51352 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
3.50794 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP1A1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MIF, MMP2, MMP9, RORC, SMAD3, SRC, TEK, TOP2A |
3.45155 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.43876 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX1, EPHX2, RORC |
3.43876 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.43634 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
3.42779 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, DRD4, GPR35 |
3.42779 |
[BP] GO:0009611 |
response to wounding
|
ACHE, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
3.41245 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.41174 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
3.38785 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.36966 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADRA2A, ADRA2C, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.36869 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.36362 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.36176 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.36176 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.36176 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
3.35837 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.34219 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1 |
3.32228 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
3.31693 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.31693 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.31693 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31693 |
[BP] GO:0002791 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
3.30932 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNA3, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
3.30497 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.29272 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.27679 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADRA2A, ADRA2C, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, PTPN1, SRC, TEK, XDH |
3.27679 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.27587 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
3.26389 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ABCG2, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.26276 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, EGFR |
3.26178 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
3.26011 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.25788 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.23425 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.23425 |
[BP] GO:0090087 |
None
|
ACHE, ADRA2A, ADRA2C, CA2, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTPN1, SMAD3, SRC |
3.2319 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DRD2, DUSP3, EGFR, KDR, MIF, PTPN1, SRC, TEK |
3.2319 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, MIF, NUAK1, PTPN1, SRC, TEK |
3.22627 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.21079 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ABCG2, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.18097 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, DRD2, DRD3, MIF, PPARA, SLC6A3, SMAD3, TEK |
3.18097 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTPN1, SMAD3, SRC |
3.17242 |
[BP] GO:0007193 |
None
|
ADRA2A, CHRM2, DRD2, DRD3, DRD4 |
3.16291 |
[BP] GO:0051952 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
3.16291 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, RORC, SMAD3, SRC |
3.15902 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.15654 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.155 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PPARA |
3.13263 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC, TOP2A |
3.1184 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.11113 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, MIF |
3.07048 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.06964 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.06964 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, INSR, KDR, MIF, NUAK1, PIM1, PPARA, RORC, SLC6A3, SMAD3, SRC, TEK, XDH |
3.03395 |
[BP] GO:1901020 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
3.0303 |
[BP] GO:0043269 |
regulation of ion transport
|
ADRA2A, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GPR35, KCNA3, MIF, MMP9 |
3.02037 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.02037 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
3.02037 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
3.02037 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.02037 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.02037 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.02037 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.02037 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.02037 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.99099 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
2.98408 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.97697 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCL2, CA2, EGFR, FLT3, SRC |
2.95543 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.95215 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.95004 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
2.93583 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.93435 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.93435 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.92187 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.9144 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.90745 |
[BP] GO:1903170 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.90002 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.90002 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTPN1, SMAD3, SRC |
2.88283 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, INSR, PTPN1, SRC |
2.88111 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.8733 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, SMAD3, XDH |
2.87166 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.86725 |
[BP] GO:0022898 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.86725 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.84116 |
[BP] GO:0050730 |
None
|
ADRA2A, ADRA2C, EGFR, FLT3, MIF, PTPN1, SRC |
2.83393 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.83393 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, EGFR, FLT3, SRC |
2.83223 |
[BP] GO:0003018 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, SRC, TEK |
2.83223 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.82063 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.82034 |
[BP] GO:0007188 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, DRD3, DRD4 |
2.82034 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.80917 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.806 |
[BP] GO:0040008 |
regulation of growth
|
BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A3, SMAD3 |
2.80028 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ABCG2, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.80028 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTPN1, SRC |
2.79677 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADRA2A, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.79158 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.79158 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.79158 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTPN1, SMAD3, SRC |
2.78879 |
[BP] GO:0050433 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.7812 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.77474 |
[BP] GO:0019725 |
cellular homeostasis
|
ABCG2, APEX1, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.77083 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.77047 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.75202 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.75202 |
[BP] GO:0055065 |
metal ion homeostasis
|
ABCG2, BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.7515 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.75098 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.74192 |
[BP] GO:0032409 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.74192 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.72472 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.72472 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.72472 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EPHX1, EPHX2, FABP3, FABP4, HSPA1A, SLC6A3, SRC, XDH |
2.71954 |
[BP] GO:0034762 |
None
|
ADRA2A, BCL2, CA2, DRD2, DRD3, DRD4, GPR35, KCNA3, MMP9 |
2.71954 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
2.70064 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.69448 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, AXL, BCL2, CHRM2, CYP1A1, DRD3, DRD4, EGFR, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC |
2.69214 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68691 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68691 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68691 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68691 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, APEX1, EGFR, ESR1, FLT3, INSR, SRC |
2.66887 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.66844 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.6668 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.66407 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.65175 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.65024 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.65024 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.65024 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.65024 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.65024 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.65024 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.65024 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.65024 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.65024 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.64428 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.63895 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1, SLC6A3 |
2.63768 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADRA2A, ADRA2C, FLT3, MIF, PTPN1, SRC |
2.63685 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.62799 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
2.62631 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.61861 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.61861 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.61164 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.60445 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.60445 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.60026 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.58845 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, INSR |
2.58845 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.58218 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.57927 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC |
2.57389 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.56307 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.56307 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
2.5525 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.52436 |
[BP] GO:0007187 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, DRD3, DRD4 |
2.52436 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.52193 |
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, PTPN1, XDH |
2.51337 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.50933 |
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, PTPN1, XDH |
2.50933 |
[BP] GO:0051128 |
regulation of cellular component organization
|
AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.4898 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.47967 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, KCNA3, PPARA, SLC6A2, SLC6A3 |
2.47513 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR |
2.47453 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ABCG2, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.45413 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.45024 |
[BP] GO:0051046 |
None
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.43989 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.42646 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.42646 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.4164 |
[BP] GO:0051254 |
None
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.4163 |
[BP] GO:0051047 |
None
|
ACHE, CYP19A1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
2.4163 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
2.4163 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, SRC |
2.4163 |
[BP] GO:0031327 |
None
|
ADRA2A, AKR1C3, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC |
2.4163 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.4163 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.4163 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.4163 |
[BP] GO:0097176 |
epoxide metabolic process
|
EPHX1, EPHX2 |
2.4163 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.4163 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.4163 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.4163 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.4163 |
[BP] GO:0051953 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.4163 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.4163 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.4163 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.4163 |
[BP] GO:0051051 |
negative regulation of transport
|
ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DRD4, GPR35, HSPA1A, MMP9 |
2.40725 |
[BP] GO:0016311 |
None
|
ALPL, APEX1, BCL2, CDC25B, DUSP3, EPHX2, PTPN1 |
2.40652 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.40614 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD2, DRD4, EGFR |
2.40532 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.40532 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
DRD2, EGFR, KDR, MIF, SRC, TEK |
2.39171 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.37442 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.37078 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.37078 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37078 |
[BP] GO:0009890 |
None
|
ADRA2A, AKR1C3, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC |
2.37034 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.35535 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.35373 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.35373 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.34965 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, MIF, MMP12, SMAD3, SRC |
2.34377 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
2.33513 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.32378 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.31236 |
[BP] GO:0003013 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, SRC, TEK |
2.31236 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.31236 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, SLC6A3 |
2.31047 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MIF, MMP9, NUAK1, PTPN1, SRC, TOP2A |
2.30879 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.28895 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.28895 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.28464 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.28464 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.28464 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, DRD2, DRD3, DRD4, EGFR |
2.28148 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, DRD2, DRD3, DRD4, EGFR |
2.28148 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.27086 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.25716 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTPN1, SRC |
2.25716 |
[BP] GO:0003008 |
None
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, BCL2, CYP1B1, DRD2, DRD3, EGFR, EPHX2, INSR, SLC6A3, SRC, TEK, TYR |
2.24217 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.24217 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.24217 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.24217 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.24217 |
[BP] GO:1901575 |
None
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FABP4, FUT7, HSPA1A, SLC6A3, XDH |
2.23611 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.2222 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.21327 |
[BP] GO:0007189 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.21327 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.21081 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, PPARA, RORC |
2.21081 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.1934 |
[BP] GO:0071383 |
None
|
AKR1C3, EGFR, FLT3, SRC |
2.17385 |
[BP] GO:0045893 |
None
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.17221 |
[BP] GO:1903508 |
None
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.17221 |
[BP] GO:1902680 |
None
|
DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TOP2A |
2.17089 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.17089 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.17089 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.16433 |
[BP] GO:0032412 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.16418 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.13977 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.13977 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, INSR, KDR, PIM1, SLC6A3, SMAD3, SRC, TEK |
2.13615 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.13449 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.13449 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.13449 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.13449 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, EGFR, SRC, TYR |
2.13111 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB |
2.13111 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR |
2.13111 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF |
2.12367 |
[BP] GO:0032845 |
None
|
ADRA2A, BCL2, DRD2, MIF, SRC |
2.11988 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
2.11362 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.11362 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.11362 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.11362 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.11362 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.11362 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.11362 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.11362 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.11362 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.11362 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.11362 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.11362 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.11362 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, SLC6A3 |
2.10976 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.1026 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MIF, SLC6A3 |
2.10178 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADRA2A, AKR1C3, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, RORC, SMAD3, SRC, TOP2A |
2.07663 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.07663 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.07663 |
[BP] GO:0008217 |
None
|
DRD2, DRD3, EPHX2, PPARA, SMAD3 |
2.07404 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.07115 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
2.06912 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, ADRA2C, DRD2, DRD3, EGFR, KDR |
2.06912 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, MIF, MMP12, SRC |
2.06912 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06912 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.0651 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, KCNA3, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.05989 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.05161 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.05161 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.0462 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, EPHX2, HSPA1A, SLC6A3, XDH |
2.0207 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.01511 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC |
2.00958 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADRA2A, ADRA2C, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GLO1, GPR35, IGF1R, INSR, KCNA3, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A3, SMAD3, SRC, TEK |
3.51657 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KCNA3, KDR, SLC6A2, SLC6A3, SRC, TEK |
3.04958 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KCNA3, KDR, SLC6A2, SLC6A3, SRC, TEK |
3.03119 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADRA2A, ADRA2C, AXL, CA2, CA4, CA9, CHRM2, DRD2, DRD3, DRD4, DUSP3, EGFR, FLT3, GPR35, IGF1R, INSR, KCNA3, KDR, MET, SLC6A2, SLC6A3, SRC, TEK |
2.95004 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADRA2A, ADRA2C, AXL, CA4, CHRM2, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
2.91669 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
2.64323 |
[CC] GO:0098589 |
membrane region
|
EGFR, INSR, KCNA3, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.60567 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.49033 |
[CC] GO:0009986 |
cell surface
|
ACHE, AXL, CA4, EGFR, MET, MIF, SLC6A2, SLC6A3, TEK |
2.17221 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCG2, ACHE, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TOP2A, TYR, XDH |
2.12187 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.11362 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADRA2A, CA2, CA4, CA9, CHRM2, DRD2, EGFR, INSR, MET, SRC, TEK |
2.07426 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADRA2A, ADRA2C, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, FLT3, FUT7, GLO1, GPR35, HSD17B2, IGF1R, INSR, KCNA3, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
2.04648 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
12.7934 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
11.6699 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.88338 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, EPHX1, EPHX2, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TOP2A, TYR, XDH |
8.79424 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A3, SRC, TEK, TOP2A |
7.71058 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
7.43552 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.38359 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
7.38359 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4, SLC6A3 |
7.33713 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.82694 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.66313 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.33031 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, ADRA2A, ADRA2C, AOX1, BCL2, CSNK2A1, DRD2, DRD4, EGFR, EPHX2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MIF, MMP9, SMAD3, TOP2A, TYR, XDH |
5.60465 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
5.53529 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
5.50021 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
5.50001 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.3067 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
5.27981 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.26345 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.25896 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.25896 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.84105 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
4.74631 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK |
4.71279 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.69822 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
4.54796 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
4.27375 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.09758 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.05739 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD17B1, HSD17B2, XDH |
4.05202 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.01727 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.80994 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.79689 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.67072 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.60561 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SLC6A3, SMAD3 |
3.60561 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, DRD4 |
3.5763 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.5763 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.43634 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.35837 |
[MF] GO:0042803 |
protein homodimerization activity
|
ABCG2, ACHE, ADRA2A, ADRA2C, AOX1, BCL2, DRD2, EPHX2, FLT3, SMAD3, TOP2A, TYR, XDH |
3.31693 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.23319 |
[MF] GO:0005102 |
receptor binding
|
ADRA2A, ADRA2C, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, PTPN1, SLC6A3, SMAD3, SRC |
3.16401 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.10727 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.02037 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.02037 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.02037 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.96921 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.83393 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.83223 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, MET, MIF, PPARA, PTPN1, SLC6A3, SMAD3, SRC, TEK, TOP2A |
2.80538 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.79158 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCG2, ADRA2A, ADRA2C, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.75202 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.65024 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.65024 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.65024 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.63895 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.63895 |
[MF] GO:0046983 |
protein dimerization activity
|
ABCG2, ACHE, ADRA2A, ADRA2C, AOX1, AXL, BCL2, DRD2, EGFR, EPHX2, FLT3, SMAD3, TOP2A, TYR, XDH |
2.62458 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.58845 |
[MF] GO:0008227 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2 |
2.52436 |
[MF] GO:0005524 |
ATP binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.43989 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.43678 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3 |
2.42981 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD17B1, HSD17B2 |
2.4164 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.4163 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADRA2A, ADRA2C, AXL, BCL2, DRD2, EGFR, SMAD3, TOP2A, TYR |
2.40532 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.39762 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.35643 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.32917 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.30921 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.28464 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.28464 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.24217 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.24217 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.24217 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.24217 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, PTPN1, SMAD3, SRC, TOP2A |
2.21327 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.20626 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.19226 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.19038 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.18533 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.17089 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.17089 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.13977 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.11988 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.11362 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.11362 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.11362 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.11362 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.11362 |
[MF] GO:0004301 |
None
|
EPHX1, EPHX2 |
2.11362 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.11362 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, PTPN1, SMAD3, SRC, TOP2A |
2.01615 |